Report Detail
Global Levonorgestrel Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4713314 |
- 29 June, 2026 |
- Global |
- 103 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Levonorgestrel market size was valued at US$ 54.24 million in 2025 and is forecast to a readjusted size of US$ 67.56 million by 2032 with a CAGR of 3.2% during review period.
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Europe is the largest Levonorgestrel market with about 43% market share. Asia-Pacific is follower, accounting for about 29% market share.The key manufacturers are Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma etc. Top 3 companies occupied about 68% market share.
This report is a detailed and comprehensive analysis for global Levonorgestrel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Levonorgestrel market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Levonorgestrel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Levonorgestrel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
Global Levonorgestrel market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Levonorgestrel
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Levonorgestrel market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Levonorgestrel market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Market segment by Application
Hospital
Drug Store
Online Sale
Major players covered
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levonorgestrel product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Levonorgestrel, with price, sales quantity, revenue, and global market share of Levonorgestrel from 2021 to 2026.
Chapter 3, the Levonorgestrel competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levonorgestrel breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Levonorgestrel market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Levonorgestrel.
Chapter 14 and 15, to describe Levonorgestrel sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Levonorgestrel Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Levonorgestrel Table
- 1.3.3 Mixture Products
- 1.3.4 Hormone-releasing IUD
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Levonorgestrel Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Drug Store
- 1.4.4 Online Sale
- 1.5 Global Levonorgestrel Market Size & Forecast
- 1.5.1 Global Levonorgestrel Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Levonorgestrel Sales Quantity (2021-2032)
- 1.5.3 Global Levonorgestrel Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Bayer
- 2.1.1 Bayer Details
- 2.1.2 Bayer Major Business
- 2.1.3 Bayer Levonorgestrel Product and Services
- 2.1.4 Bayer Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Bayer Recent Developments/Updates
- 2.2 Paladin Labs
- 2.2.1 Paladin Labs Details
- 2.2.2 Paladin Labs Major Business
- 2.2.3 Paladin Labs Levonorgestrel Product and Services
- 2.2.4 Paladin Labs Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Paladin Labs Recent Developments/Updates
- 2.3 Foundation Consumer Healthcare
- 2.3.1 Foundation Consumer Healthcare Details
- 2.3.2 Foundation Consumer Healthcare Major Business
- 2.3.3 Foundation Consumer Healthcare Levonorgestrel Product and Services
- 2.3.4 Foundation Consumer Healthcare Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Foundation Consumer Healthcare Recent Developments/Updates
- 2.4 Theramex (Teva)
- 2.4.1 Theramex (Teva) Details
- 2.4.2 Theramex (Teva) Major Business
- 2.4.3 Theramex (Teva) Levonorgestrel Product and Services
- 2.4.4 Theramex (Teva) Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Theramex (Teva) Recent Developments/Updates
- 2.5 Pfizer
- 2.5.1 Pfizer Details
- 2.5.2 Pfizer Major Business
- 2.5.3 Pfizer Levonorgestrel Product and Services
- 2.5.4 Pfizer Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Pfizer Recent Developments/Updates
- 2.6 Apotex
- 2.6.1 Apotex Details
- 2.6.2 Apotex Major Business
- 2.6.3 Apotex Levonorgestrel Product and Services
- 2.6.4 Apotex Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Apotex Recent Developments/Updates
- 2.7 HRA Pharma
- 2.7.1 HRA Pharma Details
- 2.7.2 HRA Pharma Major Business
- 2.7.3 HRA Pharma Levonorgestrel Product and Services
- 2.7.4 HRA Pharma Levonorgestrel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 HRA Pharma Recent Developments/Updates
3 Competitive Environment: Levonorgestrel by Manufacturer
- 3.1 Global Levonorgestrel Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Levonorgestrel Revenue by Manufacturer (2021-2026)
- 3.3 Global Levonorgestrel Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Levonorgestrel by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Levonorgestrel Manufacturer Market Share in 2025
- 3.4.3 Top 6 Levonorgestrel Manufacturer Market Share in 2025
- 3.5 Levonorgestrel Market: Overall Company Footprint Analysis
- 3.5.1 Levonorgestrel Market: Region Footprint
- 3.5.2 Levonorgestrel Market: Company Product Type Footprint
- 3.5.3 Levonorgestrel Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Levonorgestrel Market Size by Region
- 4.1.1 Global Levonorgestrel Sales Quantity by Region (2021-2032)
- 4.1.2 Global Levonorgestrel Consumption Value by Region (2021-2032)
- 4.1.3 Global Levonorgestrel Average Price by Region (2021-2032)
- 4.2 North America Levonorgestrel Consumption Value (2021-2032)
- 4.3 Europe Levonorgestrel Consumption Value (2021-2032)
- 4.4 Asia-Pacific Levonorgestrel Consumption Value (2021-2032)
- 4.5 South America Levonorgestrel Consumption Value (2021-2032)
- 4.6 Middle East & Africa Levonorgestrel Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Levonorgestrel Sales Quantity by Type (2021-2032)
- 5.2 Global Levonorgestrel Consumption Value by Type (2021-2032)
- 5.3 Global Levonorgestrel Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Levonorgestrel Sales Quantity by Application (2021-2032)
- 6.2 Global Levonorgestrel Consumption Value by Application (2021-2032)
- 6.3 Global Levonorgestrel Average Price by Application (2021-2032)
7 North America
- 7.1 North America Levonorgestrel Sales Quantity by Type (2021-2032)
- 7.2 North America Levonorgestrel Sales Quantity by Application (2021-2032)
- 7.3 North America Levonorgestrel Market Size by Country
- 7.3.1 North America Levonorgestrel Sales Quantity by Country (2021-2032)
- 7.3.2 North America Levonorgestrel Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Levonorgestrel Sales Quantity by Type (2021-2032)
- 8.2 Europe Levonorgestrel Sales Quantity by Application (2021-2032)
- 8.3 Europe Levonorgestrel Market Size by Country
- 8.3.1 Europe Levonorgestrel Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Levonorgestrel Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Levonorgestrel Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Levonorgestrel Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Levonorgestrel Market Size by Region
- 9.3.1 Asia-Pacific Levonorgestrel Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Levonorgestrel Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Levonorgestrel Sales Quantity by Type (2021-2032)
- 10.2 South America Levonorgestrel Sales Quantity by Application (2021-2032)
- 10.3 South America Levonorgestrel Market Size by Country
- 10.3.1 South America Levonorgestrel Sales Quantity by Country (2021-2032)
- 10.3.2 South America Levonorgestrel Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Levonorgestrel Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Levonorgestrel Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Levonorgestrel Market Size by Country
- 11.3.1 Middle East & Africa Levonorgestrel Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Levonorgestrel Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Levonorgestrel Market Drivers
- 12.2 Levonorgestrel Market Restraints
- 12.3 Levonorgestrel Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Levonorgestrel and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Levonorgestrel
- 13.3 Levonorgestrel Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Levonorgestrel Typical Distributors
- 14.3 Levonorgestrel Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Levonorgestrel. Industry analysis & Market Report on Levonorgestrel is a syndicated market report, published as Global Levonorgestrel Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Levonorgestrel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
